Clinical Trial Update: The Efficacy, Safety, And Tolerability Of Donepezil HCl (E2020) In Patients With CADASIL Who Have Cognitive Impairment [Phase 2]

View source ↗

Summary

Completed Phase 2 trial evaluating the efficacy, safety, and tolerability of donepezil hydrochloride in patients with CADASIL and cognitive impairment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy

Drugs mentioned

• Donepezil hydrochloride (Donepezil hydrochloride)

Snippet

Sponsor: Eisai Limited | Conditions: Cognitive Impairment | Phase 2 | Status: COMPLETED